Genetic basis of hypothyroidism: Recent advances, gaps and strategies for future research

Trends in Endocrinology and Metabolism

Volumn 14, Issue 7, 2003, Pages 318-326

  Moreno, José C ^a   De Vijlder, Jan J M ^a   Vulsma, Thomas ^a   Ris Stalpers, Carrie ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GENE PRODUCT; HYDROGEN PEROXIDE; THYROID HORMONE; THYROTROPIN; THYROTROPIN RECEPTOR;

CONGENITAL HYPOTHYROIDISM; DEIODINATION; GENE; GENETIC PREDISPOSITION; GENOTYPE; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MEDICAL RESEARCH; MISSENSE MUTATION; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; THRA GENE; THRB GENE; THYROID FUNCTION; TRANSCRIPTION REGULATION;

EID: 0041834828     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(03)00137-1     Document Type: Review

References (85)

1. Vulsma, T. and de Vijlder, J.J.M. (2002) Thyroid disease in newborns, infants and children. In Oxford Textbook of Endocrinology and Diabetes (Wass, J.A. and Shalet, S.M., eds), pp. 532-544, Oxford University Press
2. Castanet, M. et al. (2001) Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J. Clin. Endocrinol. Metab. 86, 2009-2014
3. Damante, G. et al. (2001) A unique combination of transcription factors controls differentiation of thyroid cells. Prog. Nucleic Acid Res. Mol. Biol. 66, 307-356
4. Revest, J.M. et al. (2001) Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf10, Msx, or Bmp4. Dev. Biol. 231, 47-62
5. Mendelsohn, C. et al. (1994) Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120, 2749-2771
6. Martinez-Barbera, J.P. et al. (2000) The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation. Development 127, 2433-2445
7. Manley, N.R. and Capecchi, M.R. (1995) The role of Hoxa-3 in mouse thymus and thyroid development. Development 121, 1989-2003
8. Xu, P-X. et al. (2002) Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. Development 129, 3033-3044
9. Wendl, T. et al. (2002) Pax2.1 is required for the development of thyroid follicles in zebrafish. Development 129, 3751-3760
10. Dathan, N. et al. (2002) Distribution of the titf2/foxe1 gene product is consistent with an important role in the development of foregut endoderm, palate and hair. Dev. Dyn. 224, 450-456
11. De Felice, M. et al. (1998) A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat. Genet. 19, 395-398
12. Clifton-Bligh, R.J. et al. (1998) Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat. Genet. 19, 399-401
13. Castanet, M. et al. (2002) A novel loss-of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis and cleft palate. Hum. Mol. Genet. 11, 2051-2059
14. Mansouri, A. et al. (1998) Follicular cells of the thyroid gland require Pax8 gene function. Nat. Genet. 19, 87-90
15. Congdon, T. et al. (2001) A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism and thyroid hypoplasia: evidence for phenotypic variability in mother and child. J. Clin. Endocrinol. Metab. 86, 3962-3967
16. Nutt, S.L. et al. (1999) Independent regulation of the two Pax5 alleles during B-cell development. Nat. Genet. 21, 390-395
17. De Felice, M. et al. (2002) Thyroid dysgenesis: a multigenic disease. J. Endocrinol. Invest. 25 (Suppl. 7), 4
18. Tell, G. et al. (1998) Ref-1 controls Pax-8 DNA-binding activity. Biochem. Biophys. Res. Commun. 252, 178-183
19. Kimura, S. et al. (1996) The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain and pituitary. Genes Dev. 10, 60-69
20. Kimura, S. et al. (1999) Thyroid-specific enhancer-binding protein/ thyroid transcription factor 1 is not required for the initial specification of the thyroid and lung primordia. Biochimie 81, 321-327
21. Krude, H. et al. (2002) Choreoathetosis, hypothyroidism and pulmonary alterations due to human NKX2-1 haploinsufficiency. J. Clin. Invest. 109, 475-480
22. Pohlenz, J. et al. (2002) Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J. Clin. Invest. 109, 469-473
23. Kopp, P. (2001) The TSH receptor and its role in thyroid disease. Cell. Mol. Life Sci. 58, 1301-1322
24. Stein, S.A. et al. (1994) Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol. Endocrinol. 8, 129-138
25. Postiglione, M.P. et al. (2002) Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc. Natl. Acad. Sci. U. S. A. 99, 15462-15467
26. Marians, R.C. et al. (2002) Defining thyrotropin-dependent and independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc. Natl. Acad. Sci. U. S. A. 99, 15776-15781
27. Alberti, L. et al. (2002) Germline mutations of the TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 87, 2549-2555
28. Sunthornthepvarakul, T. et al. (1995) Resistance to thyrotropin caused by mutations in the thyrotropin receptor gene. N. Engl. J. Med. 332, 155-160
29. Weinstein, L.S. et al. (2001) Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting. Endocr. Rev. 22, 675-705
30. Xie, J. et al. (1997) Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. J. Clin. Endocrinol. Metab. 82, 3933-3940
31. Nguyen, L.Q. et al. (2000) A dominant negative CREB (cAMP response element-binding protein) isoform inhibits thyrocyte growth, thyroid-specific gene expression, differentiation and function. Mol. Endocrinol. 14, 1448-1461
32. Dohan, O. et al. (2003) The sodium/iodide symporter (NIS): characterization, regulation and medical significance. Endocr. Rev. 24, 48-77
33. Dohan, O. et al. (2000) Molecular study of the sodium-iodide symporter (NIS): a new field in thyroidology. Trends Endocrinol. Metab. 11, 99-105
34. Dohan, O. et al. (2002) Na(+)/I(-) symporter activity requires a small and uncharged amino acid residue at position 395. Mol. Endocrinol. 16, 1893-1902
35. Ricketts, M.H. et al. (1987) A nonsense mutation causes hereditary goiter in the Afrikander cattle and unmasks alternative splicing of thyroglobulin transcripts. Proc. Natl. Acad. Sci. U. S. A. 84, 3181-3184
36. Veenboer, G.J.M. and de Vijlder, J.J.M. (1993) Molecular basis of the thyroglobulin synthesis defect in Dutch goats. Endocrinology 132, 377-381
37. Kim, P.S. et al. (1998) A single amino acid change in the acetylcholinesterase-like domain of thyroglobulin causes congenital goiter with hypothyroidism in the cog/cog mouse: a model of human endoplasmic reticulum storage diseases. Proc. Natl. Acad. Sci. U. S. A. 95, 9909-9913
38. Hishinuma, A. et al. (2000) A novel missense mutation (G2320R) in thyroglobulin causes hypothyroidism in rdw rats. Endocrinology 141, 4050-4055
39. Medeiros-Neto, G. et al. (1993) Defective thyroglobulin synthesis and secretion causing goiter and hypothyroidism. Endocr. Rev. 14, 165-183
40. Gonzalez-Sarmiento, R. et al. (2001) Monoallelic deletion in the 5′ region of the thyroglobulin gene as a cause of sporadic non-endemic goiter. Thyroid 11, 789-793
41. Van de Graaf, S.A.R. et al. (1999) The screening for mutations in the thyroglobulin cDNA from six patients with congenital hypothyroidism. Biochimie 81, 425-432
42. Bakker, B. et al. (2000) Two decades of screening for congenital hypothyroidism in the Netherlands: TPO mutations in total iodide organification defects (an update). J. Clin. Endocrinol. Metab. 85, 3708-3712
43. Umeki, K. et al. (2002) Two novel missense mutations in the thyroid peroxidase gene, R665W and G771R, result in a localization defect and cause congenital hypothyroidism. Eur. J. Endocrinol. 146, 491-498
44. Sjollema, B.E. et al. (1991) Congenital hypothyroidism in two cats due to defective organification: data suggesting loosely anchored thyroperoxidase. Acta Endocrinol. 125, 435-440
45. Santos, C.L. et al. (1999) A novel mutation in the TPO gene in goitrous hypothyroid patients with iodide organification defect. Clin. Endocrinol. 51, 165-172
46. De Deken, X. et al. (2000) Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J. Biol. Chem. 275, 23227-23233
47. Moreno, J.C. et al. (2002) Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N. Engl. J. Med. 347, 95-102
48. Edens, W.A. et al. (2001) Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J. Cell Biol. 154, 879-891
49. Everett, L.A. et al. (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat. Genet. 17, 411-422
50. Yoshida, A. et al. (2002) Pendrin is an iodide-specific apical porter responsible for iodide efflux from thyroid cells. J. Clin. Endocrinol. Metab. 87, 3356-3361
51. Everett, L.A. et al. (2001) Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum. Mol. Genet. 10, 153-161
52. Rotman-Pikielny, P. et al. (2002) Retention of pendrin in the endoplasmic reticulum is a major mechanism for Pendred syndrome. Hum. Mol. Genet. 11, 2625-2633
53. Masmoudi, S. et al. (2000) Pendred syndrome: phenotypic variability in two families carrying the same PDS missense mutation. Am J. Med. Genet. 90, 38-44
54. Scott, D.A. et al. (2000) Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum. Mol. Genet. 9, 1709-1715
55. Rodriguez, A.M. et al. (2002) Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J. Clin. Endocrinol. Metab. 87, 3500-3503
56. 2-generating system. Exp. Cell Res. 273, 187-196
57. Medeiros-Neto, G. and Stanbury, J.B. (1994) The iodotyrosine deiodinase defect. Inherited Disorders of the Thyroid System, pp. 139-159, Boca Raton CRC Press
58. Moreno, J.C. et al. (2002) Cloning and characterization of a novel thyroidal gene encoding proteins with a conserved nitroreductase domain. J. Endocrinol. Invest. 25 (Suppl. 7), 23
59. Scully, K.M. and Rosenfeld, M.G. (2002) Pituitary development: regulatory codes in mammalian organogenesis. Science 295, 2231-2235
60. Dattani, M.T. et al. (1998) Mutations in the homeobox gene HESX1/ Hesxl associated with septooptic dysplasia in human and mouse. Nat. Genet. 19, 125-133
61. Netchine, I. et al. (2000) Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat. Genet. 25, 182-186
62. Medeiros-Neto, G. et al. (1996) A circulating, biologically inactive thyrotropin caused by a mutation in the β subunit gene. J. Clin. Invest. 97, 1250-1256
63. Collu, R. et al. (1997) A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J. Clin. Endocrinol. Metab. 82, 1561-1565
64. Yamada, M. et al. (1997) Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc. Natl. Acad. Sci. U. S. A. 94, 10862-10867
65. Stahl, J.H. et al. (1999) Thyroid hormone is essential for pituitary somatotropes and lactotropes. Endocrinology 140, 1884-1892
66. Ito, M. et al. (2000) Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. Mol. Cell 5, 683-693
67. Nakabayashi, K. et al. (2002) Thyrostimulin, a heterodimer oftwo new human glycoprotein hormone subunits, activates the thyroid stimulating hormone receptor. J. Clin. Invest. 109, 1445-1452
68. Prummel, M.F. et al. (2000) Expression of the thyroid stimulating hormone receptor in the folliculo-stellate cells of the human anterior pituitary. J. Clin. Endocrinol. Metab. 85, 4347-4353
69. Refetoff, S. et al. (1993) The syndromes of resistance to thyroid hormones. Endocr. Rev. 14, 348-399
70. Brent, G.A. (2000) Tissue-specific actions of thyroid hormone: insights from animal models. Rev. Endocr. Metab. Disord. 1, 27-33
71. Pohlenz, J. et al. (1999) Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor β gene. J. Clin. Endocrinol. Metab. 84, 3919-3928
72. Brown, N.S. et al. (2000) Thyroid hormone resistance and increased metabolic rate in the RXR-γ-deficient mouse. J. Clin. Invest. 106, 73-79
73. Weiss, R.E. et al. (1999) Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO J. 18, 1900-1904
74. Abe, T. et al. (2002) Thyroid hormone transporters: recent advances. Trends Endocrinol. Metab. 13, 215-220
75. Kohrle, J. (2000) The deiodinase family: selenoenzymes regulating thyroid hormone availability and action. Cell. Mol. Life Sci. 57, 1853-1863
76. Huang, S.A. et al. (2000) Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N. Engl. J. Med. 343, 185-189
77. Berry, M.J. et al. (1993) Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5′ deiodinase deficiency. J. Clin. Invest. 92, 1517-1528
78. Schneider, M.J. et al. (2001) Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol. Endocrinol. 15, 2137-2148
79. Soulet, D. and Rivest, S. (2002) How to make microarray, serial analysis of gene expression and proteomic relevant to day-to-day endocrine problems and physiological systems. Endocrinology 143, 1995-2001
80. Velculescu, V.E. et al. (1999) Analysis of human transcriptomes. Nat. Genet. 23, 387-388
81. Moreno, J.C. et al. (2001) Cloning of tissue-specific genes using serial analysis of gene expression and a novel computational subtraction approach. Genomics 75, 70-76
82. Vitt, U.A. et al. (2001) Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Mol. Endocrinol. 15, 681-694
83. Perez-Iratxeta, C. et al. (2002) Association of genes to genetically inherited diseases using data mining. Nat. Genet. 31, 316-319
84. Perry, R. et al. (2002) Discordance of monozygotic twins for thyroid dysgenesis: implications for screening and for molecular pathophysiology. J. Clin. Endocrinol. Metab. 87, 4072-4077
85. Van de Graaf, S.A.R. et al. (2001) Up to date with human thyroglobulin. J. Endocrinol. 170, 307-321